{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:27:07Z","timestamp":1794230827720,"version":"4.9.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaapos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaapos.2026.105306","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:31:33Z","timestamp":1790836293000},"page":"105306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zone II stage 2 retinopathy of prematurity without plus disease: long-term follow-up and predictors of persistent avascular retina"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5633-9036","authenticated-orcid":false,"given":"Puren","family":"Isik Eker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer","family":"Yap\u0131c\u0131oglu Y\u0131ldiztas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Demircan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulya","family":"Binokay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"382","key":"10.1016\/j.jaapos.2026.105306_bib1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"6","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaapos.2026.105306_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3061","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaapos.2026.105306_bib3","first-page":"234","article-title":"Fluorescein angiography to estimate normal peripheral retinal nonperfusion in children","volume":"16","author":"Blair","year":"2012","journal-title":"JAAPOS"},{"key":"10.1016\/j.jaapos.2026.105306_bib4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.clp.2014.08.011","article-title":"Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity","volume":"41","author":"Hartnett","year":"2014","journal-title":"Clin Perinatol"},{"issue":"56","key":"10.1016\/j.jaapos.2026.105306_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3928\/01913913-20190501-01","article-title":"Persistent avascular retina in infants with a history of type 2 retinopathy of prematurity: to treat or not to treat?","volume":"1","author":"Al-Taie","year":"2019","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.jaapos.2026.105306_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaapos.2022.10.003","article-title":"Characteristics of babies with unstable clinical course screened for retinopathy of prematurity","volume":"27","author":"Patnaik","year":"2023","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaapos.2026.105306_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/08820538.2022.2085518","article-title":"Fluorescein angiography findings in treatment-naive premature infants with retinal vascular immaturity and persistent avascular retina","volume":"37","author":"Bayramo\u011flu","year":"2022","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.105306_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.oret.2019.01.016","article-title":"Fluorescein angiography in retinopathy of prematurity: comparison of infants treated with bevacizumab to those with spontaneous regression","volume":"3","author":"Mansukhani","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jaapos.2026.105306_bib9","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1007\/s10792-018-01064-7","article-title":"Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression","volume":"39","author":"Vural","year":"2019","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.jaapos.2026.105306_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100281","article-title":"Persistent vascular anomalies in retinopathy of prematurity children: ultrawide-field fluorescein angiography findings until school age","volume":"7","author":"Ling","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.jaapos.2026.105306_bib11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.oret.2019.12.015","article-title":"Late-onset retinal findings and complications in untreated retinopathy of prematurity","volume":"4","author":"Hamad","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jaapos.2026.105306_bib12","first-page":"29","article-title":"Prevalence of persistent avascular retina in untreated children with a history of retinopathy of prematurity screening","volume":"26","author":"Hanif","year":"2022","journal-title":"JAAPOS"},{"issue":"8","key":"10.1016\/j.jaapos.2026.105306_bib13","article-title":"Clinical features of spontaneous regression of retinopathy of prematurity in china: a 5-year retrospective case series","volume":"31","author":"Wang","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"13","key":"10.1016\/j.jaapos.2026.105306_bib14","article-title":"Evaluation of retinal vascularization in retinopathy of prematurity regressed after intravitreal ranibizumab monotherapy or without treatment based on fluorescein angiography","volume":"15","author":"Wu","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaapos.2026.105306_bib15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10792-021-02119-y","article-title":"Angiographic findings in cases with a history of severe retinopathy of prematurity treated with anti-VEGFs: Follow-up to age 6 years","volume":"42","author":"Celiker","year":"2022","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.105306_bib16","first-page":"1217","article-title":"Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis","volume":"41","author":"Hughes","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaapos.2026.105306_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/07853890.2015.1029967","article-title":"Novel relationships between oxidative stress and angiogenesis related factors in sepsis: new biomarkers and therapies","volume":"47","author":"Vera","year":"2015","journal-title":"Ann Med"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853126005793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853126005793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T12:55:09Z","timestamp":1794228909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853126005793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1091853126005793"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2026.105306","relation":{},"ISSN":["1091-8531"],"issn-type":[{"value":"1091-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zone II stage 2 retinopathy of prematurity without plus disease: long-term follow-up and predictors of persistent avascular retina","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2026.105306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Association for Pediatric Ophthalmology and Strabismus.","name":"copyright","label":"Copyright"}],"article-number":"105306"}}